Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5Five@slrpnk.net to World News@beehaw.org – 216 points – 8 months agofortune.com34Post a CommentPreviewYou are viewing a single commentView all commentsShow the parent commentYou can look it up: https://www.novonordisk.com/partnering-and-open-innovation/open-innovation/private-public-partnerships.htmlnothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.1 more...1 more...
You can look it up: https://www.novonordisk.com/partnering-and-open-innovation/open-innovation/private-public-partnerships.htmlnothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.1 more...1 more...
nothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.1 more...
You can look it up: https://www.novonordisk.com/partnering-and-open-innovation/open-innovation/private-public-partnerships.html
nothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.